Skip to main content

Peer Review reports

From: Health professionals’ preferences with the use of pegfilgrastim on-body injector at oncology centers in 8 cities in Colombia

Original Submission
4 Aug 2022 Submitted Original manuscript
20 Aug 2022 Author responded Author comments - María Alejandra Larrarte-Gonzalez
Resubmission - Version 2
20 Aug 2022 Submitted Manuscript version 2
9 Sep 2022 Reviewed Reviewer Report - Davide Costa
23 Sep 2022 Reviewed Reviewer Report
21 Nov 2022 Author responded Author comments - María Alejandra Larrarte-Gonzalez
Resubmission - Version 3
21 Nov 2022 Submitted Manuscript version 3
25 Nov 2022 Author responded Author comments - María Alejandra Larrarte-Gonzalez
Resubmission - Version 4
25 Nov 2022 Submitted Manuscript version 4
1 Dec 2022 Author responded Author comments - María Alejandra Larrarte-Gonzalez
Resubmission - Version 5
1 Dec 2022 Submitted Manuscript version 5
25 Jan 2023 Author responded Author comments - María Alejandra Larrarte-Gonzalez
Resubmission - Version 6
25 Jan 2023 Submitted Manuscript version 6
9 Feb 2023 Author responded Author comments - María Alejandra Larrarte-Gonzalez
Resubmission - Version 7
9 Feb 2023 Submitted Manuscript version 7
14 Feb 2023 Reviewed Reviewer Report
21 Feb 2023 Reviewed Reviewer Report
16 Mar 2023 Author responded Author comments - María Alejandra Larrarte-Gonzalez
Resubmission - Version 8
16 Mar 2023 Submitted Manuscript version 8
4 Apr 2023 Reviewed Reviewer Report
23 Apr 2023 Author responded Author comments - María Alejandra Larrarte-Gonzalez
Resubmission - Version 9
23 Apr 2023 Submitted Manuscript version 9
Publishing
26 Apr 2023 Editorially accepted
23 May 2023 Article published 10.1186/s12913-023-09454-z

You can find further information about peer review here.

Back to article page